Intranasal Administration of GRP78 Protein (HSPA5) Counteracts the Neurodegeneration in the Locus Coeruleus in a Model of Chronic Sleep Restriction in Rats
{"title":"Intranasal Administration of GRP78 Protein (HSPA5) Counteracts the Neurodegeneration in the Locus Coeruleus in a Model of Chronic Sleep Restriction in Rats","authors":"M. B. Pazi, I. V. Ekimova","doi":"10.1134/s002209302404029x","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Abstract</h3><p>Chronic sleep restriction (SR) (sleep less than 6 hours per\nday) due to the workload and a decrease in sleep quality is an endemic\ndisease in modern society. Chronic sleep deprivation causes serious neuropsychiatric\ndisfunctions associated with irreversible neurodegenerative changes\nin the brain. The search for pharmacological agents that can reduce\nthe risk of neurodegeneration as a result of chronic sleep loss\nis a pressing issue for biomedicine. Intranasal administration of\nglucose-regulated 78 kDa heat shock protein (GRP78) has a neuroprotective\neffect in a rat model of Parkinson’s disease (PD). The neuroprotective\npotential of intranasally administered GRP78 in chronic SR has not\nbeen previously studied. The aim of the present study was to find\nout whether preventive intranasal administration of GRP78 is able\nto weaken and/or stop the process of neurodegeneration in the locus\ncoeruleus in the rat model of chronic SR. The study was conducted\non 6 months old male Wistar rats. For SR, a validated method of\na oscillating platform was used: 3 hours of sleep deprivation and\n1 hour of rest continuously for 5 days. Recombinant human protein\nGRP78 was administered intranasally two days before the start of\nSR and during 5 days of SR. Cellular and molecular changes in the\nlocus coeruleus during SR and during the administration of GRP78\nwere studied using immunohistochemistry and Western blotting. It was\nshown that chronic SR leads to the degeneration of 31% of noradrenergic\nneurons in the locus coeruleus, that is associated with an increase\nin the levels of activated caspases-3 and -9. This indicates the\ndevelopment of apoptosis along the mitochondrial pathway. No signs\nof reactive microgliosis were found in the model of chronic SR in\nrats. We have demonstrated that intranasally administered GRP78 penetrates\nand accumulates in the neurons of the locus coeruleus, GRP78 counteracts\nthe death of neurons via the apoptosis pathway. The data obtained\nallows to consider GRP78 as a potential neuroprotective agent for\nthe prevention of pathological consequences of chronic SR.</p>","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1134/s002209302404029x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Chronic sleep restriction (SR) (sleep less than 6 hours per
day) due to the workload and a decrease in sleep quality is an endemic
disease in modern society. Chronic sleep deprivation causes serious neuropsychiatric
disfunctions associated with irreversible neurodegenerative changes
in the brain. The search for pharmacological agents that can reduce
the risk of neurodegeneration as a result of chronic sleep loss
is a pressing issue for biomedicine. Intranasal administration of
glucose-regulated 78 kDa heat shock protein (GRP78) has a neuroprotective
effect in a rat model of Parkinson’s disease (PD). The neuroprotective
potential of intranasally administered GRP78 in chronic SR has not
been previously studied. The aim of the present study was to find
out whether preventive intranasal administration of GRP78 is able
to weaken and/or stop the process of neurodegeneration in the locus
coeruleus in the rat model of chronic SR. The study was conducted
on 6 months old male Wistar rats. For SR, a validated method of
a oscillating platform was used: 3 hours of sleep deprivation and
1 hour of rest continuously for 5 days. Recombinant human protein
GRP78 was administered intranasally two days before the start of
SR and during 5 days of SR. Cellular and molecular changes in the
locus coeruleus during SR and during the administration of GRP78
were studied using immunohistochemistry and Western blotting. It was
shown that chronic SR leads to the degeneration of 31% of noradrenergic
neurons in the locus coeruleus, that is associated with an increase
in the levels of activated caspases-3 and -9. This indicates the
development of apoptosis along the mitochondrial pathway. No signs
of reactive microgliosis were found in the model of chronic SR in
rats. We have demonstrated that intranasally administered GRP78 penetrates
and accumulates in the neurons of the locus coeruleus, GRP78 counteracts
the death of neurons via the apoptosis pathway. The data obtained
allows to consider GRP78 as a potential neuroprotective agent for
the prevention of pathological consequences of chronic SR.